nVision Medical Corp, a clinical-stage, privately-held medical device company, today announced a $12 million Series B financing. The proceeds will be used to support further product development, clinical studies, and regulatory submissions for nVision’s patented micro-catheter technology.
SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System® (“iFuse”), announced the publication of the 40th peer-reviewed paper on SI joint fusion with iFuse. The paper, titled Durable intermediate to long-term outcomes after minimally invasive transiliac sacroiliac joint fusion using triangular titanium implants, shows mean 3.7-year follow-up for minimally invasive SI joint fusion was associated with improved pain, low disability scores, improved ability to perform activities of daily living and low revision rates.
A San Francisco native with an MBA from Wharton and experience working at two successful medical device startups in the Bay area, Jan Garfinkle was a trailing spouse when she moved to Michigan over 20 years ago. At the time, there were less than ten venture capital firms in existence in Michigan. Today there are 25, including Arboretum Ventures, which Jan founded in 2002 and remains a Managing Director today.